http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200524908-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae84948901b77f34fd51c41264d8d19c |
| filingDate | 2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edb4694bf845f51757da453f29918ea3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_298b535e132ee01f8626bb7619c44092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0b5129479075f22bfb5bbdbc797cbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7af4f92f8990ec9ccf56bcdc149faf |
| publicationDate | 2005-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200524908-A |
| titleOfInvention | 1H-imidazole derivatives as cannabinoid receptor modulators |
| abstract | The invention relates to a group of 1H-imidazole derivatives which are modulators of cannabinoid receptors, to methods for the preparation of these compounds, to novel intermediates useful for the synthesis of said imidazole derivatives, to methods for the preparation of these intermediates, to pharmaceutical compositions containing one or more of these 1H-imidazole derivatives as active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of psychiatric and neurological disorders in which cannabinoid receptors are involved. The compounds have the general formula (I), Wherein R, R, -Ra and X have the meanings given in the specification. |
| priorityDate | 2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.